Elevating Our Communities With Every Interaction

Velocity is the world's leading integrated site organization.

Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.

Simplify everything from site selection to study close-out

Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.

Research sites across the U.S. and Europe
+
Investigators with diverse experience
+
Clinical trials conducted since 1986
treatment
mother-and-child-2
Hallandale
caring african medical nurse comforting senior patient in office
Velocity-team-office

The right sites.
The right investigators.
The right partner for you.

Strategically located to give you access to diverse specialty populations, Velocity's sites are supported by next-gen technologies and patient engagement capabilities. Welcome to recruitment and retention reimagined.

Scale for a purpose: Supporting research programs worldwide

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health.

Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, contact Velocity.

News

Paul Evans Named Among the Top 50 Healthcare Technology CEOs of 2024

January 8, 2025

Congratulations to Paul Evans for being named one of the Top 50 Healthcare Technology CEOs of 2024! With Paul’s leadership, Velocity continues to redefine how clinical trials are conducted — … Read more

Velocity Contributes to ACRP Whitepaper on Responsible AI Oversight

January 7, 2025

Velocity’s team contributed to the new Association of Clinical Research Professionals (ACRP) comprehensive whitepaper, titled ‘Responsible Oversight of Artificial Intelligence for Clinical Research Professionals.’ The development of our VISION technology … Read more

BioSpace Opinion: The Cocktail Recipe That Will Cure Alzheimer’s

January 6, 2025

Robert Cupelo, MD, Principal Investigator in Syracuse, NY, shares his firsthand insights into the evolving landscape of Alzheimer’s treatment. Nearly two years after the FDA’s approval of lecanemab (Leqembi), and … Read more

Fierce Biotech Article: Paul Evans on Clinical Trials in 2025

December 30, 2024

A new Fierce Biotech article features insights from Paul Evans on what to expect for clinical research in 2025. Topics include rising costs and uncertain regulations, as well as the … Read more

Quality. Continuity. Velocity.